TrialThe New England journal of medicine2017
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Tony S Mok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,886 papers cite itlatest 60 shown
this paperpooled ittrialcites it